HEADER VIRAL PROTEIN/IMMUNE SYSTEM 10-MAR-22 7X7V TITLE CRYO-EM STRUCTURE OF SARS-COV SPIKE PROTEIN IN COMPLEX WITH THREE NABS TITLE 2 X01, X10 AND X17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: X10 LIGHT CHAIN; COMPND 3 CHAIN: L; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: X10 HEAVY CHAIN; COMPND 6 CHAIN: H; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: X17 LIGHT CHAIN; COMPND 9 CHAIN: F; COMPND 10 MOL_ID: 4; COMPND 11 MOLECULE: X17 HEAVY CHAIN; COMPND 12 CHAIN: A; COMPND 13 MOL_ID: 5; COMPND 14 MOLECULE: X01 LIGHT CHAIN; COMPND 15 CHAIN: D; COMPND 16 MOL_ID: 6; COMPND 17 MOLECULE: X01 HEAVY CHAIN; COMPND 18 CHAIN: C; COMPND 19 MOL_ID: 7; COMPND 20 MOLECULE: SPIKE PROTEIN S1; COMPND 21 CHAIN: E; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 6 ORGANISM_TAXID: 10090; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_TAXID: 10090; SOURCE 10 MOL_ID: 4; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 MOL_ID: 5; SOURCE 14 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 15 ORGANISM_TAXID: 10090; SOURCE 16 MOL_ID: 6; SOURCE 17 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 18 ORGANISM_TAXID: 10090; SOURCE 19 MOL_ID: 7; SOURCE 20 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS; SOURCE 21 ORGANISM_COMMON: SARS-COV; SOURCE 22 ORGANISM_TAXID: 694009; SOURCE 23 GENE: S, 2; SOURCE 24 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, NEUTRALIZING ANTIBODY, CRYO-EM, VIRAL PROTEIN, VIRAL KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR H.SUN,L.LIU,T.ZHANG,Q.ZHENG,S.LI,N.XIA REVDAT 2 23-NOV-22 7X7V 1 JRNL REVDAT 1 17-AUG-22 7X7V 0 JRNL AUTH H.XIONG,H.SUN,S.WANG,L.YUAN,L.LIU,Y.ZHU,J.ZHANG,Y.HUANG, JRNL AUTH 2 R.QI,Y.JIANG,J.MA,M.ZHOU,Y.MA,R.FU,S.YAN,M.YUE,Y.WU,M.WEI, JRNL AUTH 3 Y.WANG,T.LI,Y.WANG,Z.ZHENG,H.YU,T.CHENG,S.LI,Q.YUAN,J.ZHANG, JRNL AUTH 4 Y.GUAN,Q.ZHENG,T.ZHANG,N.XIA JRNL TITL THE NEUTRALIZING BREADTH OF ANTIBODIES TARGETING DIVERSE JRNL TITL 2 CONSERVED EPITOPES BETWEEN SARS-COV AND SARS-COV-2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 56119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 35972965 JRNL DOI 10.1073/PNAS.2204256119 REMARK 2 REMARK 2 RESOLUTION. 3.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.830 REMARK 3 NUMBER OF PARTICLES : 230838 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7X7V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1300027797. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV REMARK 245 SPIKE PROTEIN IN COMPLEX WITH REMARK 245 THREE NABS X01, X10 AND X17; REMARK 245 NABS X01, X10 AND X17; SARS-COV REMARK 245 SPIKE PROTEIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEPTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, F, A, D, C, E, B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS E 366 CA - CB - SG ANGL. DEV. = 9.4 DEGREES REMARK 500 PRO E 507 CA - N - CD ANGL. DEV. = -12.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 55 -10.23 68.05 REMARK 500 SER L 56 -36.35 -132.19 REMARK 500 SER H 40 78.95 -101.64 REMARK 500 ASP H 90 52.35 -92.29 REMARK 500 SER H 104 11.82 -142.88 REMARK 500 ASP A 55 14.81 -140.88 REMARK 500 PHE A 64 31.14 -94.08 REMARK 500 TYR A 104 49.09 -94.23 REMARK 500 ASN D 31 13.03 -144.75 REMARK 500 ASP D 82 53.87 -93.51 REMARK 500 TYR D 91 38.94 -143.24 REMARK 500 SER C 31 -60.73 -93.64 REMARK 500 LYS C 43 -169.10 -124.05 REMARK 500 TYR C 103 -63.86 -93.17 REMARK 500 TYR E 352 18.53 56.49 REMARK 500 THR E 363 -71.30 -76.04 REMARK 500 ALA E 371 50.03 -93.40 REMARK 500 GLN E 401 69.04 60.74 REMARK 500 ILE E 428 -61.23 -100.48 REMARK 500 HIS E 445 95.99 -69.41 REMARK 500 PRO E 470 47.77 -85.63 REMARK 500 ALA E 471 -164.85 -79.66 REMARK 500 LEU E 504 28.00 46.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-33049 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV SPIKE PROTEIN IN COMPLEX WITH THREE REMARK 900 NABS X01, X10 AND X17 DBREF 7X7V L 1 111 PDB 7X7V 7X7V 1 111 DBREF 7X7V H 1 121 PDB 7X7V 7X7V 1 121 DBREF 7X7V F 1 107 PDB 7X7V 7X7V 1 107 DBREF 7X7V A 1 119 PDB 7X7V 7X7V 1 119 DBREF 7X7V D 1 107 PDB 7X7V 7X7V 1 107 DBREF 7X7V C 1 119 PDB 7X7V 7X7V 1 119 DBREF 7X7V E 320 508 UNP P59594 SPIKE_SARS 320 508 SEQRES 1 L 111 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 L 111 SER LEU GLY GLN ARG ALA ALA ILE SER CYS ARG ALA SER SEQRES 3 L 111 GLN SER VAL SER THR SER SER HIS ASN TYR VAL HIS TRP SEQRES 4 L 111 TYR GLN GLN ARG PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 L 111 LYS TYR ALA SER ASN LEU GLU CYS GLY VAL PRO ALA ARG SEQRES 6 L 111 PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU ASN SEQRES 7 L 111 ILE HIS PRO VAL GLU GLU GLU ASP SER ALA ALA TYR TYR SEQRES 8 L 111 CYS GLN HIS SER TRP GLU ILE PRO TYR THR PHE GLY GLY SEQRES 9 L 111 GLY THR LYS LEU GLU ILE LYS SEQRES 1 H 121 GLU VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 H 121 PRO GLY ALA SER VAL LYS ILE SER CYS LYS THR SER GLY SEQRES 3 H 121 TYR THR PHE THR GLU TYR THR LEU HIS TRP VAL LYS GLN SEQRES 4 H 121 SER HIS GLY LYS SER LEU GLU TRP ILE GLY GLY PHE ASP SEQRES 5 H 121 PRO ASN PHE GLY GLY ALA THR TYR ASN LEU LYS PHE GLU SEQRES 6 H 121 ASP LYS ALA THR LEU THR VAL ASP LYS SER SER ASN THR SEQRES 7 H 121 ALA TYR MET GLU LEU ARG SER LEU THR SER GLU ASP SER SEQRES 8 H 121 ALA VAL PHE TYR CYS ALA ARG GLY ASP TYR GLY THR SER SEQRES 9 H 121 TYR ALA TYR PHE ASP PHE TRP GLY GLN GLY THR THR LEU SEQRES 10 H 121 THR VAL SER SER SEQRES 1 F 107 ASP ILE GLN MET THR GLN THR THR SER SER LEU SER ALA SEQRES 2 F 107 SER LEU GLY ASP ARG VAL THR ILE SER CYS ARG ALA SER SEQRES 3 F 107 GLN ASP ILE SER ASN TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 F 107 PRO ASP GLY THR VAL LYS LEU LEU ILE TYR TYR THR SER SEQRES 5 F 107 ARG LEU HIS SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 F 107 GLY SER GLY THR ASP TYR SER LEU THR ILE SER ASN LEU SEQRES 7 F 107 GLU GLN GLU ASP ILE ALA THR TYR PHE CYS GLN GLN GLY SEQRES 8 F 107 THR THR LEU PRO TYR THR PHE GLY GLY GLY THR LYS LEU SEQRES 9 F 107 GLU ILE LYS SEQRES 1 A 119 GLN VAL GLN LEU GLN GLN SER GLY ALA GLU LEU ALA ARG SEQRES 2 A 119 PRO GLY ALA SER VAL LYS LEU SER CYS LYS ALA SER GLY SEQRES 3 A 119 TYR THR PHE THR PHE TYR TRP MET GLN TRP LEU LYS GLN SEQRES 4 A 119 ARG PRO GLY GLN GLY LEU GLU TRP ILE GLY ALA ILE TYR SEQRES 5 A 119 PRO GLY ASP GLY ASP THR ARG TYR THR GLN ARG PHE LYS SEQRES 6 A 119 ASP LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 A 119 ALA TYR ILE GLN LEU SER SER LEU ALA SER GLU ASP SER SEQRES 8 A 119 ALA VAL TYR TYR CYS ALA GLY GLY GLU TYR ASP ASN TYR SEQRES 9 A 119 GLY PHE ASP TYR TRP GLY GLN GLY THR THR LEU THR VAL SEQRES 10 A 119 SER SER SEQRES 1 D 107 ASP ILE GLN MET THR GLN SER SER SER TYR LEU SER VAL SEQRES 2 D 107 SER LEU GLY GLY ARG VAL THR ILE THR CYS LYS ALA SER SEQRES 3 D 107 ASP HIS ILE ASN ASN TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 D 107 PRO GLY ASN ALA PRO ARG LEU LEU ILE SER GLY VAL THR SEQRES 5 D 107 ASN LEU GLU THR GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 D 107 GLY SER GLY LYS ASN PHE THR LEU SER ILE ALA SER LEU SEQRES 7 D 107 GLN THR GLU ASP VAL ALA THR TYR TYR CYS GLN GLN TYR SEQRES 8 D 107 TRP SER PHE PRO TRP THR PHE GLY GLY GLY THR LYS LEU SEQRES 9 D 107 GLU ILE ARG SEQRES 1 C 119 GLU ILE GLN LEU GLN GLN SER GLY PRO GLU LEU VAL ALA SEQRES 2 C 119 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 C 119 TYR ALA PHE THR SER TYR ASN MET TYR TRP VAL ARG GLN SEQRES 4 C 119 SER HIS GLY LYS SER LEU GLU TRP ILE GLY TYR ILE VAL SEQRES 5 C 119 PRO TYR ASN GLY GLY THR THR TYR ASN GLN GLU PHE LYS SEQRES 6 C 119 GLY LYS ALA THR LEU THR VAL ASP LYS SER SER ASN THR SEQRES 7 C 119 ALA TYR ILE HIS LEU ASN SER LEU THR SER GLU ASP SER SEQRES 8 C 119 ALA VAL TYR TYR CYS ALA LYS GLU GLY THR TYR TYR GLY SEQRES 9 C 119 TYR ASP GLY VAL LEU ALA ASP TRP GLY GLN GLY THR LEU SEQRES 10 C 119 VAL THR SEQRES 1 E 189 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 E 189 LYS PHE PRO SER VAL TYR ALA TRP GLU ARG LYS LYS ILE SEQRES 3 E 189 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 E 189 THR PHE PHE SER THR PHE LYS CYS TYR GLY VAL SER ALA SEQRES 5 E 189 THR LYS LEU ASN ASP LEU CYS PHE SER ASN VAL TYR ALA SEQRES 6 E 189 ASP SER PHE VAL VAL LYS GLY ASP ASP VAL ARG GLN ILE SEQRES 7 E 189 ALA PRO GLY GLN THR GLY VAL ILE ALA ASP TYR ASN TYR SEQRES 8 E 189 LYS LEU PRO ASP ASP PHE MET GLY CYS VAL LEU ALA TRP SEQRES 9 E 189 ASN THR ARG ASN ILE ASP ALA THR SER THR GLY ASN TYR SEQRES 10 E 189 ASN TYR LYS TYR ARG TYR LEU ARG HIS GLY LYS LEU ARG SEQRES 11 E 189 PRO PHE GLU ARG ASP ILE SER ASN VAL PRO PHE SER PRO SEQRES 12 E 189 ASP GLY LYS PRO CYS THR PRO PRO ALA LEU ASN CYS TYR SEQRES 13 E 189 TRP PRO LEU ASN ASP TYR GLY PHE TYR THR THR THR GLY SEQRES 14 E 189 ILE GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE SEQRES 15 E 189 GLU LEU LEU ASN ALA PRO ALA HET NAG B 1 14 HET NAG B 2 14 HET NAG G 1 14 HET NAG G 2 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 8 NAG 4(C8 H15 N O6) HELIX 1 AA1 ASN H 61 GLU H 65 5 5 HELIX 2 AA2 ALA A 87 SER A 91 5 5 HELIX 3 AA3 TYR A 101 GLY A 105 5 5 HELIX 4 AA4 GLN C 62 LYS C 65 5 4 HELIX 5 AA5 PRO E 324 PHE E 329 1 6 HELIX 6 AA6 SER E 336 TRP E 340 5 5 HELIX 7 AA7 ASP E 392 VAL E 394 5 3 HELIX 8 AA8 THR E 425 ALA E 430 1 6 SHEET 1 AA1 4 LEU L 4 SER L 7 0 SHEET 2 AA1 4 ALA L 19 ALA L 25 -1 O SER L 22 N SER L 7 SHEET 3 AA1 4 ASP L 74 ILE L 79 -1 O PHE L 75 N CYS L 23 SHEET 4 AA1 4 PHE L 66 SER L 69 -1 N SER L 67 O ASN L 78 SHEET 1 AA2 5 SER L 10 ALA L 12 0 SHEET 2 AA2 5 THR L 106 GLU L 109 1 O GLU L 109 N LEU L 11 SHEET 3 AA2 5 ALA L 89 HIS L 94 -1 N TYR L 90 O THR L 106 SHEET 4 AA2 5 VAL L 37 GLN L 42 -1 N TYR L 40 O TYR L 91 SHEET 5 AA2 5 LYS L 49 LEU L 50 -1 O LYS L 49 N GLN L 41 SHEET 1 AA3 2 ILE L 52 LYS L 53 0 SHEET 2 AA3 2 ASN L 57 LEU L 58 -1 O ASN L 57 N LYS L 53 SHEET 1 AA4 4 GLN H 3 GLN H 6 0 SHEET 2 AA4 4 VAL H 18 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA4 4 THR H 78 LEU H 83 -1 O ALA H 79 N CYS H 22 SHEET 4 AA4 4 ALA H 68 ASP H 73 -1 N THR H 71 O TYR H 80 SHEET 1 AA5 4 GLU H 46 TRP H 47 0 SHEET 2 AA5 4 TYR H 32 GLN H 39 -1 N LYS H 38 O GLU H 46 SHEET 3 AA5 4 VAL H 93 TYR H 101 -1 O ALA H 97 N HIS H 35 SHEET 4 AA5 4 THR H 115 THR H 116 -1 O THR H 115 N PHE H 94 SHEET 1 AA6 3 MET F 4 THR F 5 0 SHEET 2 AA6 3 VAL F 19 ALA F 25 -1 O ARG F 24 N THR F 5 SHEET 3 AA6 3 ASP F 70 ILE F 75 -1 O TYR F 71 N CYS F 23 SHEET 1 AA7 2 SER F 10 ALA F 13 0 SHEET 2 AA7 2 LYS F 103 ILE F 106 1 O LYS F 103 N LEU F 11 SHEET 1 AA8 4 VAL F 44 ILE F 48 0 SHEET 2 AA8 4 LEU F 33 GLN F 38 -1 N GLN F 37 O LYS F 45 SHEET 3 AA8 4 THR F 85 GLN F 90 -1 O PHE F 87 N TYR F 36 SHEET 4 AA8 4 THR F 97 PHE F 98 -1 O THR F 97 N GLN F 90 SHEET 1 AA9 4 GLN A 3 GLN A 6 0 SHEET 2 AA9 4 CYS A 22 SER A 25 -1 O LYS A 23 N GLN A 5 SHEET 3 AA9 4 THR A 78 LEU A 83 -1 O ALA A 79 N CYS A 22 SHEET 4 AA9 4 VAL A 18 LYS A 19 -1 N VAL A 18 O LEU A 83 SHEET 1 AB1 4 GLN A 3 GLN A 6 0 SHEET 2 AB1 4 CYS A 22 SER A 25 -1 O LYS A 23 N GLN A 5 SHEET 3 AB1 4 THR A 78 LEU A 83 -1 O ALA A 79 N CYS A 22 SHEET 4 AB1 4 ALA A 68 ASP A 73 -1 N THR A 71 O TYR A 80 SHEET 1 AB2 5 THR A 58 TYR A 60 0 SHEET 2 AB2 5 LEU A 45 ILE A 51 -1 N ALA A 50 O ARG A 59 SHEET 3 AB2 5 GLN A 35 GLN A 39 -1 N TRP A 36 O ILE A 48 SHEET 4 AB2 5 VAL A 93 GLY A 98 -1 O TYR A 95 N LEU A 37 SHEET 5 AB2 5 TYR A 108 TRP A 109 -1 O TYR A 108 N GLY A 98 SHEET 1 AB3 5 THR A 58 TYR A 60 0 SHEET 2 AB3 5 LEU A 45 ILE A 51 -1 N ALA A 50 O ARG A 59 SHEET 3 AB3 5 GLN A 35 GLN A 39 -1 N TRP A 36 O ILE A 48 SHEET 4 AB3 5 VAL A 93 GLY A 98 -1 O TYR A 95 N LEU A 37 SHEET 5 AB3 5 THR A 113 THR A 114 -1 O THR A 113 N TYR A 94 SHEET 1 AB4 4 MET D 4 GLN D 6 0 SHEET 2 AB4 4 VAL D 19 ALA D 25 -1 O LYS D 24 N THR D 5 SHEET 3 AB4 4 PHE D 71 ILE D 75 -1 O LEU D 73 N ILE D 21 SHEET 4 AB4 4 SER D 63 SER D 65 -1 N SER D 65 O THR D 72 SHEET 1 AB5 2 TYR D 10 LEU D 11 0 SHEET 2 AB5 2 LYS D 103 LEU D 104 1 O LYS D 103 N LEU D 11 SHEET 1 AB6 4 ASN D 53 LEU D 54 0 SHEET 2 AB6 4 ARG D 45 SER D 49 -1 N SER D 49 O ASN D 53 SHEET 3 AB6 4 LEU D 33 GLN D 38 -1 N TRP D 35 O LEU D 47 SHEET 4 AB6 4 THR D 85 GLN D 90 -1 O GLN D 89 N ALA D 34 SHEET 1 AB7 4 GLN C 3 GLN C 6 0 SHEET 2 AB7 4 VAL C 18 SER C 25 -1 O LYS C 23 N GLN C 5 SHEET 3 AB7 4 THR C 78 LEU C 83 -1 O ALA C 79 N CYS C 22 SHEET 4 AB7 4 ALA C 68 ASP C 73 -1 N ASP C 73 O THR C 78 SHEET 1 AB8 5 THR C 58 TYR C 60 0 SHEET 2 AB8 5 LEU C 45 ILE C 51 -1 N TYR C 50 O THR C 59 SHEET 3 AB8 5 MET C 34 SER C 40 -1 N ARG C 38 O GLU C 46 SHEET 4 AB8 5 ALA C 92 GLU C 99 -1 O ALA C 97 N TYR C 35 SHEET 5 AB8 5 LEU C 109 TRP C 112 -1 O ALA C 110 N LYS C 98 SHEET 1 AB9 5 THR C 58 TYR C 60 0 SHEET 2 AB9 5 LEU C 45 ILE C 51 -1 N TYR C 50 O THR C 59 SHEET 3 AB9 5 MET C 34 SER C 40 -1 N ARG C 38 O GLU C 46 SHEET 4 AB9 5 ALA C 92 GLU C 99 -1 O ALA C 97 N TYR C 35 SHEET 5 AB9 5 THR C 116 LEU C 117 -1 O THR C 116 N TYR C 94 SHEET 1 AC1 5 GLU E 341 ILE E 345 0 SHEET 2 AC1 5 VAL E 382 LYS E 390 -1 O VAL E 382 N ILE E 345 SHEET 3 AC1 5 PRO E 493 LEU E 499 -1 O TYR E 494 N VAL E 389 SHEET 4 AC1 5 CYS E 419 ASN E 424 -1 N LEU E 421 O VAL E 497 SHEET 5 AC1 5 LYS E 365 CYS E 366 -1 N LYS E 365 O VAL E 420 SHEET 1 AC2 2 LYS E 439 ARG E 441 0 SHEET 2 AC2 2 LEU E 478 ASP E 480 -1 O ASN E 479 N TYR E 440 SSBOND 1 CYS L 23 CYS L 92 1555 1555 2.04 SSBOND 2 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 3 CYS F 23 CYS F 88 1555 1555 2.03 SSBOND 4 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 5 CYS D 23 CYS D 88 1555 1555 2.03 SSBOND 6 CYS C 22 CYS C 96 1555 1555 2.03 SSBOND 7 CYS E 323 CYS E 348 1555 1555 2.03 SSBOND 8 CYS E 366 CYS E 419 1555 1555 1.98 SSBOND 9 CYS E 467 CYS E 474 1555 1555 2.04 LINK ND2 ASN E 330 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN E 357 C1 NAG G 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.44 CISPEP 1 SER L 7 PRO L 8 0 -2.67 CISPEP 2 LEU F 94 PRO F 95 0 0.48 CISPEP 3 PRO E 469 PRO E 470 0 11.98 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000